欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FI/H/1220/001
药品名称Apixaban Viatris Pharma 2,5 mg Film-coated tablet
活性成分
    • Apixaban 2.5 mg
剂型Film-coated tablet
上市许可持有人Viatris Limited Damastown Industrial Park, Mulhuddart D15XD71 Dublin Ireland
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Slovakia (SK)
    • Germany (DE)
      Apixaban Taw 2,5 mg Filmtabletten
    • Greece (GR)
    • Slovenia (SI)
    • Denmark (DK)
      Apixaban Viatris Pharma
    • Sweden (SE)
    • Malta (MT)
      Apixaban / Taw Pharma 2,5 mg Film Coated Tablets
    • Belgium (BE)
      Apixaban Viatris Pharma 2,5 mg filmomhulde tabletten
    • Norway (NO)
    • Netherlands (NL)
    • Latvia (LV)
    • Luxembourg (LU)
    • Lithuania (LT)
      Apixaban Taw Pharma 2,5 mg plėvele dengtos tabletės
    • Iceland (IS)
    • Estonia (EE)
    • Ireland (IE)
    • Hungary (HU)
      Apixaban Taw Pharma 2,5 mg filmtabletta
    • Austria (AT)
    • Bulgaria (BG)
      Apixaban Taw Pharma
    • France (FR)
    • Cyprus (CY)
      Apixaban / Taw Pharma 2,5 mg Film Coated Tablets
    • Spain (ES)
    • Czechia (CZ)
      Apixaban Taw Pharma
    • Portugal (PT)
    • Romania (RO)
    • Italy (IT)
许可日期2025/05/16
最近更新日期2025/06/19
药物ATC编码
    • B01AF02 apixaban
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase